Skip to content

    Xenon Pharmaceuticals (XENE) stock price & financials

    View XENE earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+54.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $0
    $0
    $7.50M
    $0
    $0
    $0
    $0
    -100.0%
    $0
    Weakening
    Operating Profit
    -$73.68M
    -$77.48M
    -$72.74M
    -$94.23M
    -$96.34M
    -30.8%
    -$109.77M
    -41.7%
    -$112.33M
    -54.4%
    -$123.16M
    -30.7%
    Weakening
    Net Profit
    -$62.79M
    -$65.69M
    -$65.05M
    -$84.71M
    -$90.90M
    -44.8%
    -$105.26M
    -60.3%
    -$102.30M
    -57.3%
    -$110.74M
    -30.7%
    Weakening
    EPS
    $-0.81
    $-0.83
    $-1.07
    $-1.15
    -42.0%
    $-1.17
    -41.0%
    $-1.11
    -3.7%
    Weakening
    Other Income
    $10.57M
    $7.94M
    $8.12M
    $8.90M
    $6.12M
    -42.1%
    $5.04M
    -36.5%
    $7.46M
    -8.2%
    $11.83M
    +33.0%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    -$63.11M
    -$69.53M
    -$64.62M
    -$85.33M
    -$90.22M
    -43.0%
    -$104.72M
    -50.6%
    -$104.87M
    -62.3%
    -$111.32M
    -30.5%
    Weakening
    MarginsOPM
    -969.8%
    Tax
    0.5%
    5.5%
    -0.7%
    0.7%
    -0.8%
    -247.1%
    -0.5%
    -109.2%
    2.5%
    0.5%
    -27.4%
    Weakening
    ReturnsROIC
    -40.0%
    -41.8%
    -41.4%
    -53.9%
    -57.9%
    -44.8%
    -67.0%
    -60.3%
    -65.1%
    -57.3%
    -70.5%
    -30.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$67.75M$24.75M$45.01M$175.69M$57.24M$148.64M$142.71M$199.16M$119.53M
    Short-Term Investments$51.55M$116.60M$131.99M$376.09M$534.85M$489.44M$484.19M$349.72M$811.16M
    Total Current Assets$121.33M$144.87M$181.78M$559.02M$600.30M$644.96M$635.26M$560.65M$945.87M
    Net PP&E$991.0K$2.59M$6.88M$12.52M$16.91M$18.85M$18.22M$15.35M$13.16M
    Goodwill
    Intangibles
    Total Assets$122.43M$147.70M$189.19M$572.01M$754.15M$964.80M$798.14M$633.16M$1.30B
    LiabilitiesTotal Current Liabilities$4.12M$43.38M$14.78M$14.32M$22.70M$27.27M$35.59M$41.79M$45.01M
    Short-Term Debt$4.65M
    Long-Term Debt$15.01M$10.89M
    Long-Term Leases$743.0K$3.05M$7.65M$9.95M$9.60M$7.65M$6.41M$5.08M
    Total Liabilities$19.13M$55.72M$17.83M$21.97M$32.65M$36.88M$43.24M$51.40M$53.38M
    EquityCommon Stock & APIC$265.92M$294.24M$397.75M$783.17M$1.07B$1.44B$1.46B$1.60B$2.43B
    Retained Earnings-$207.88M-$249.66M-$278.49M-$357.37M-$482.75M-$665.14M-$899.47M-$1.25B-$1.46B
    Total Equity$103.30M$91.98M$171.35M$550.03M$721.50M$927.92M$754.90M$581.76M$1.24B
    HighlightsNet Cash / (Debt)$125.82M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$34.72M-$4.71M-$48.12M-$69.50M-$101.03M-$151.11M-$181.39M-$279.12M-$337.52M
    Cash from Investing-$28.99M-$66.21M-$16.82M-$246.77M-$293.40M-$111.39M$165.00M$218.00M-$637.29M
    Cash from Financing$111.59M$27.52M$85.80M$447.54M$278.47M$353.52M$12.13M$117.11M$958.94M
    SummaryCapital Expenditure-$507.0K-$1.24M-$2.64M-$2.05M-$2.89M-$5.62M-$3.08M-$799.0K-$1.01M
    Free Cash Flow-$35.23M-$5.95M-$50.76M-$71.55M-$103.92M-$156.73M-$184.46M-$279.92M-$338.53M
    FCF Margin-87.2%-157.8%-388.1%-1101.6%-3732.2%

    Ratios